Live feed
Filing
SC 13G
SC 13G0001213900-19-018908·Aurinia Pharmaceuticals Inc.
Schedule 13G ownership disclosure
Aurinia Pharmaceuticals Inc
Security class unavailable · CUSIP: 05156V102
Event date: 2019-09-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,290,228
- Percent of class
- 1.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-018908
- Form type
- SC 13G
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Sep 25, 2019
- Reporting period
- Sep 16, 2019
- Description
- Schedule 13G beneficial ownership